SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 89 filers reported holding SCHOLAR ROCK HLDG CORP in Q3 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $183,890 | +15.5% | 25,900 | +22.6% | 0.00% | – |
| Q2 2023 | $159,275 | +360.0% | 21,124 | +388.1% | 0.00% | – |
| Q1 2023 | $34,624 | +235.0% | 4,328 | +279.0% | 0.00% | – |
| Q4 2022 | $10,335 | +106.7% | 1,142 | +56.0% | 0.00% | – |
| Q3 2022 | $5,000 | -16.7% | 732 | -29.1% | 0.00% | – |
| Q2 2022 | $6,000 | -70.0% | 1,032 | +45.8% | 0.00% | – |
| Q2 2021 | $20,000 | -81.0% | 708 | -87.8% | 0.00% | – |
| Q2 2020 | $105,000 | +22.1% | 5,785 | -18.2% | 0.00% | – |
| Q1 2020 | $86,000 | -66.8% | 7,070 | -64.0% | 0.00% | – |
| Q4 2019 | $259,000 | +91.9% | 19,636 | +30.1% | 0.00% | – |
| Q3 2019 | $135,000 | +150.0% | 15,091 | +346.5% | 0.00% | – |
| Q2 2019 | $54,000 | +1.9% | 3,380 | +47.1% | 0.00% | – |
| Q4 2018 | $53,000 | +39.5% | 2,298 | +56.6% | 0.00% | – |
| Q3 2018 | $38,000 | -19.1% | 1,467 | -51.3% | 0.00% | – |
| Q2 2018 | $47,000 | – | 3,011 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 4,598,828 | $31,870,000 | 7.43% |
| Artal Group S.A. | 8,750,034 | $60,638,000 | 2.59% |
| Redmile Group, LLC | 3,140,026 | $21,760,000 | 0.84% |
| Bellevue Group AG | 2,152,025 | $14,914,000 | 0.21% |
| Corton Capital Inc. | 10,462 | $73,000 | 0.09% |
| Orbimed Advisors | 667,943 | $4,629,000 | 0.09% |
| Delphia (USA) Inc. | 10,657 | $74,000 | 0.08% |
| CAXTON ASSOCIATES LP | 73,264 | $508,000 | 0.07% |
| PDT Partners, LLC | 43,605 | $302,000 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 29,906 | $207,000 | 0.04% |